Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
about
Anticancer and anti-inflammatory properties of chitin and chitosan oligosaccharidesNovel delivery approaches for cancer therapeutics.Stem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapy.Photoluminescent Mesoporous Silicon Nanoparticles with siCCR2 Improve the Effects of Mesenchymal Stromal Cell Transplantation after Acute Myocardial InfarctionOral delivery of capsaicin using MPEG-PCL nanoparticlesChitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasisImpact of siRNA targeting of β-catenin on differentiation of rat neural stem cells and gene expression of Ngn1 and BMP4 following in vitro hypoxic-ischemic brain damageSalvianolic acid B protects against myocardial damage caused by nanocarrier TiO2; and synergistic anti-breast carcinoma effect with curcumin via codelivery system of folic acid-targeted and polyethylene glycol-modified TiO2 nanoparticlesVintafolide (EC145) for the treatment of folate-receptor-α positive platinum-resistant ovarian cancer.Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy.Synthesis and preliminary evaluation of a 99m Tc-labeled folate-PAMAM dendrimer for FR imaging.Insights into the therapeutic potential of hypoxia-inducible factor-1α small interfering RNA in malignant melanoma delivered via folate-decorated cationic liposomes.Folate-mediated chemotherapy and diagnostics: An updated review and outlook.Dual MMP7-proximity-activated and folate receptor-targeted nanoparticles for siRNA delivery.Fabrication of self-assembled folate-biotin-quaternized starch nanoparticles as co-carrier of doxorubicin and siRNA.Delivery of siRNA silencing P-gp in peptide-functionalized nanoparticles causes efflux modulation at the blood-brain barrier.
P2860
Q28084795-EBB45031-4B15-4FA3-9BC6-1C3EA696BAD5Q30368171-7D0AA043-906E-4132-9660-526AC7BD2C33Q33653485-D3952DC3-6DC8-49C2-A48D-639A910F09C5Q35868864-4F5C3A4B-64F3-4FB6-A9AA-F934E5F1CFF7Q36063707-B30BB394-87CC-40CE-BF44-ED299A97114EQ36161065-1A41EA4B-0F72-4C68-82EC-75D88D32D8BCQ37297425-32DBB731-93EA-4D83-BEF3-DF66022C9544Q37398335-4F413E5A-11D0-4F8C-ACB9-344B5F729D10Q38205273-9C9A3CA7-3C39-480A-B3A2-5139A3970583Q38542764-306D2ECC-4349-4087-9151-FD04B86DC06BQ38727932-DFAC0C08-DBD7-49AC-B832-DC824542E18FQ38780952-2E0B48D3-7BCB-4B37-BD84-140742482B9CQ39149880-4555A764-684F-4910-91A0-14482A29C652Q43105872-AE82AB17-BE6C-46A4-A9C8-D21164382B29Q47875471-D6C296B0-5DDA-405C-9625-8710F2722D60Q52094378-B60E9329-DC14-48A1-A3AC-AAE463FCBB74
P2860
Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Efficient siRNA delivery and t ...... d ovarian cancer gene therapy.
@ast
Efficient siRNA delivery and t ...... d ovarian cancer gene therapy.
@en
type
label
Efficient siRNA delivery and t ...... d ovarian cancer gene therapy.
@ast
Efficient siRNA delivery and t ...... d ovarian cancer gene therapy.
@en
prefLabel
Efficient siRNA delivery and t ...... d ovarian cancer gene therapy.
@ast
Efficient siRNA delivery and t ...... d ovarian cancer gene therapy.
@en
P2093
P921
P1476
Efficient siRNA delivery and t ...... d ovarian cancer gene therapy.
@en
P2093
Koichi Honke
Tony Shing Chau Li
Toshio Yawata
P356
10.1016/J.EJPS.2013.10.011
P407
P577
2013-10-29T00:00:00Z